Hochschulschrift
LOH-Analysen von BRCA1-, BRCA2- und TP53-Markern in spontanen Mammakarzinomen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
70 Bl.
- Language
-
Deutsch
- Notes
-
Düsseldorf, Univ., Diss., 2001
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.0003, 6:33 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
LOH-Analyse von BRCA1- und TP53-Markern in sporadischen Endometriumkarzinomen
Verlust der Heterozygotität in der BRCA1_Region bei spontanen Mammakarzinomen
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
Fall-Kontroll-Studie mit Fluoreszenz-in-Situ-Hybridisierung an paraffineingebetteten Mammakarzinomen zum Nachweis von TP53- und Chromosom-17-Aberrationen
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report
Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service
Die spontanen Hodennekrosen
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Zytomorphometrische Untersuchungen an Mammakarzinomen
Steroidhormonrezeptoren in menschlichen Mammakarzinomen
Histomorphometrische Untersuchungen an Mammakarzinomen
LOH-Analyse von BRCA1- und TP53-Markern in sporadischen Endometriumkarzinomen
Verlust der Heterozygotität in der BRCA1_Region bei spontanen Mammakarzinomen
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
Fall-Kontroll-Studie mit Fluoreszenz-in-Situ-Hybridisierung an paraffineingebetteten Mammakarzinomen zum Nachweis von TP53- und Chromosom-17-Aberrationen
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report
Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service
Die spontanen Hodennekrosen
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Zytomorphometrische Untersuchungen an Mammakarzinomen
Steroidhormonrezeptoren in menschlichen Mammakarzinomen
Histomorphometrische Untersuchungen an Mammakarzinomen
LOH-Analyse von BRCA1- und TP53-Markern in sporadischen Endometriumkarzinomen
Verlust der Heterozygotität in der BRCA1_Region bei spontanen Mammakarzinomen
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
Fall-Kontroll-Studie mit Fluoreszenz-in-Situ-Hybridisierung an paraffineingebetteten Mammakarzinomen zum Nachweis von TP53- und Chromosom-17-Aberrationen
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report
Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service
Die spontanen Hodennekrosen
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Zytomorphometrische Untersuchungen an Mammakarzinomen
Steroidhormonrezeptoren in menschlichen Mammakarzinomen